---

Afrigen Biologics and Vaccines, based in Cape Town, is a biotechnology company focused on developing and manufacturing vaccine adjuvants and biologics, providing local African capacity for vaccine innovation and supply. Founded in 2014 through partnership between Infectious Disease Research Institute (USA) and IDC, acquired by Avacare in 2017. Cape Town-based biotech company focusing on vaccine adjuvant formulations, biologics, stability storage, mRNA hub, contract analytical services. First adjuvant production centre in Africa. Unique as continent’s first local vaccine adjuvant developer.

---